84 related articles for article (PubMed ID: 2674860)
1. Coexistence of a c-myc mRNA initiated in intron 1 with the normal c-myc mRNA and similar regulation of both transcripts in mammalian cells.
Ray D; Robert-Lézénès J
Oncogene Res; 1989; 5(1):73-8. PubMed ID: 2674860
[TBL] [Abstract][Full Text] [Related]
2. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters.
Kohlhuber F; Strobl LJ; Eick D
Oncogene; 1993 Apr; 8(4):1099-102. PubMed ID: 8455938
[TBL] [Abstract][Full Text] [Related]
3. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
[TBL] [Abstract][Full Text] [Related]
4. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
Darling D; Tavassoli M; Linskens MH; Farzaneh F
Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
[TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
Prochownik EV; Kukowska J
Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
[TBL] [Abstract][Full Text] [Related]
6. Analysis of c-myc expression in a human hepatoma cell line.
Huber BE; Thorgeirsson SS
Cancer Res; 1987 Jul; 47(13):3414-20. PubMed ID: 3034414
[TBL] [Abstract][Full Text] [Related]
7. Presence of a c-myc transcript initiated in intron 1 in Friend erythroleukemia cells and in other murine cell types with no evidence of c-myc gene rearrangement.
Ray D; Meneceur P; Tavitian A; Robert-Lezenes J
Mol Cell Biol; 1987 Feb; 7(2):940-5. PubMed ID: 3547087
[TBL] [Abstract][Full Text] [Related]
8. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
[TBL] [Abstract][Full Text] [Related]
9. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
Eick D; Polack A; Kofler E; Bornkamm GW
Oncogene; 1988 Oct; 3(4):397-403. PubMed ID: 3078949
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
Richon VM; Ramsay RG; Rifkind RA; Marks PA
Oncogene; 1989 Feb; 4(2):165-73. PubMed ID: 2648254
[TBL] [Abstract][Full Text] [Related]
11. The level of c-myc transcript in differentiation-defective mouse erythroleukemia cells.
Sasaki H; Watanabe T; Nomura S; Oishi M
Jpn J Cancer Res; 1987 Aug; 78(8):776-9. PubMed ID: 3115922
[TBL] [Abstract][Full Text] [Related]
12. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression.
Re GG; Antoun GR; Zipf TF
Oncogene; 1990 Aug; 5(8):1247-50. PubMed ID: 1697411
[TBL] [Abstract][Full Text] [Related]
13. A transcriptional arrest mechanism involved in controlling constitutive levels of mouse c-myb mRNA.
Watson RJ
Oncogene; 1988 Mar; 2(3):267-72. PubMed ID: 3281094
[TBL] [Abstract][Full Text] [Related]
14. Effects of IL-3 on promoter usage, attenuation and antisense transcription of the c-myc oncogene in the IL-3-dependent Ba/F3 early pre-B cell line.
Chang Y; Spicer DB; Sonenshein GE
Oncogene; 1991 Nov; 6(11):1979-82. PubMed ID: 1682864
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
16. Regulation of c-myc mRNA levels by insulin or platelet-poor plasma.
Gai XX; Rizzo MG; Valpreda S; Baserga R
Oncogene Res; 1989; 5(2):111-20. PubMed ID: 2691956
[TBL] [Abstract][Full Text] [Related]
17. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
[TBL] [Abstract][Full Text] [Related]
18. Expression of P0- and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells.
Eick D; Polack A; Kofler E; Lenoir GM; Rickinson AB; Bornkamm GW
Oncogene; 1990 Sep; 5(9):1397-402. PubMed ID: 2216463
[TBL] [Abstract][Full Text] [Related]
19. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
20. Changes in promoter utilization in human and mouse c-myc genes upon transformation induction in temperature-sensitive cell lines.
Luo Y; Krause MO
J Cell Physiol; 1994 Aug; 160(2):303-15. PubMed ID: 8040189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
